OverviewSuggest Edit

Ukko is a company that builds a comprehensive, clinically validated map of the molecular structure of food allergies and disorders, acquiring knowledge on the biological mechanisms that drive human food interactions. The company aims to develop foods that are safe and healthy for everyone to eat, starting with two of the most common triggers, peanuts, and wheat.

TypePrivate
Founded2016
HQTel Aviv-Yafo, IL
Websiteukko.us

Latest Updates

Employees (est.) (Sept 2021)40(+9%)
Cybersecurity ratingBMore

Key People/Management at Ukko

Anat Binur

Anat Binur

Co-Founder
Yanay Ofran

Yanay Ofran

Co-Founder
Show more

Ukko Office Locations

Ukko has offices in Tel Aviv-Yafo and Palo Alto
Palo Alto, CA, US
1845 El Camino Real
Show all (2)

Ukko Financials and Metrics

Summary Metrics

Founding Date

2016

Ukko total Funding

$47.7 m

Ukko latest funding size

$40 m

Time since last funding

8 months ago

Ukko investors

Ukko's latest funding round in January 2021 was reported to be $40 m. In total, Ukko has raised $47.7 m
Show all financial metrics

Ukko Cybersecurity Score

Cybersecurity ratingPremium dataset

B

86/100

SecurityScorecard logo

Ukko Online and Social Media Presence

Embed Graph

Ukko News and Updates

Ukko raises $40 million to address food allergies with AI

Ukko, a startup developing food allergy treatments using AI, has raised $40 million in a venture capital round.

Ukko Frequently Asked Questions

  • When was Ukko founded?

    Ukko was founded in 2016.

  • Who are Ukko key executives?

    Ukko's key executives are Anat Binur and Yanay Ofran.

  • How many employees does Ukko have?

    Ukko has 40 employees.

  • Who are Ukko competitors?

    Competitors of Ukko include Just-Evotec Biologics, Cellink and D&D Pharmatech.

  • Where are Ukko offices?

    Ukko has offices in Tel Aviv-Yafo and Palo Alto.

  • How many offices does Ukko have?

    Ukko has 2 offices.